These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20488262)

  • 21. Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina.
    DiBiase LM; Davis SE; Rosselli R; Horney J
    Vaccine; 2011 May; 29(23):3969-76. PubMed ID: 21477677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global production capacity of seasonal influenza vaccine in 2011.
    Partridge J; Kieny MP
    Vaccine; 2013 Jan; 31(5):728-31. PubMed ID: 23149268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
    Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic influenza: imminent threat, preparedness and the divided globe.
    Chaturvedi S
    Indian Pediatr; 2009 Feb; 46(2):115-21. PubMed ID: 19242025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina.
    Orellano PW; Reynoso JI; Carlino O; Uez O
    Vaccine; 2010 Jul; 28(32):5288-91. PubMed ID: 20541580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.
    Chlibek R; Anca I; André F; Bakir M; Ivaskeviciene I; Mangarov A; Mészner Z; Perenovska P; Prymula R; Richter D; Salman N; Simurka P; Tamm E; Toplak N; Usonis V
    Vaccine; 2010 May; 28(22):3758-66. PubMed ID: 20380902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The safety and immunogenicity of the vaccines against pandemic (H1N1) 2009 influenza].
    Grotto I; Engelhard D
    Harefuah; 2009 Dec; 148(12):799-803, 857. PubMed ID: 20088428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
    Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
    N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H1N1 vaccine for prevention of pandemic influenza.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):77-8. PubMed ID: 19798010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
    Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
    Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poverty, wealth, and access to pandemic influenza vaccines.
    Yamada T
    N Engl J Med; 2009 Sep; 361(12):1129-31. PubMed ID: 19675324
    [No Abstract]   [Full Text] [Related]  

  • 32. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
    Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terrapinn's world influenza congress Europe 2009. Part 1.
    Veryard C
    IDrugs; 2010 Feb; 13(2):76-7. PubMed ID: 20127555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing cell culture-derived pandemic vaccines.
    Barrett PN; Portsmouth D; Ehrlich HJ
    Curr Opin Mol Ther; 2010 Feb; 12(1):21-30. PubMed ID: 20140813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.
    Del Rio C; Hernandez-Avila M
    Arch Med Res; 2009 Nov; 40(8):677-80. PubMed ID: 20304256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swine flu pandemic review panel seeks access to confidential documents between WHO and drug companies.
    Zarocostas J
    BMJ; 2010 May; 340():c2792. PubMed ID: 20501574
    [No Abstract]   [Full Text] [Related]  

  • 39. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(3):74-7. PubMed ID: 20110935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. After the pandemic.
    Nature; 2010 Aug; 466(7309):903. PubMed ID: 20724995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.